Prostacyclin receptor desensitization is a reversible phenomenon in human platelets

Area of Science:

• Platelet biology
• Receptor pharmacology
• Cardiovascular research

Background:

• Prostacyclin receptor desensitization can occur with prolonged exposure to prostacyclin or its analogues.
• This desensitization involves reduced receptor density and impaired response to prostacyclins.
• Reversibility of this platelet desensitization process remains largely uninvestigated.

Purpose of the Study:

• To investigate the reversibility of prostacyclin receptor desensitization in human platelets.
• To determine if internalized prostacyclin receptors can be recycled to the platelet surface.
• To assess the functional recovery of platelets after agonist withdrawal.

Main Methods:

• Human platelets were desensitized using the prostacyclin analogue iloprost.
• Internalized receptors were identified using saponin permeabilization and [3H]-iloprost binding.
• Platelet sensitivity to iloprost was measured by aggregation, serotonin release, and p-selectin expression.
• Receptor binding properties (Bmax, KD) and cAMP formation were assessed after iloprost withdrawal.

Main Results:

• Iloprost desensitization significantly reduced [3H]-iloprost binding sites, which were recovered by saponin permeabilization, indicating internalized receptors.
• Platelet sensitivity to iloprost inhibition of aggregation, serotonin release, and p-selectin expression was restored within 3 hours of iloprost withdrawal.
• Iloprost-stimulated cAMP formation also recovered, and [3H]-iloprost binding parameters returned to baseline levels.

Conclusions:

• Internalized prostacyclin receptors are not degraded during short-term desensitization.
• These receptors are rapidly recycled to the platelet surface after agonist withdrawal.
• Recycled receptors are functionally active, restoring platelet responsiveness to prostacyclins.